| Deal Structure and Party Summary | ||
|---|---|---|
| Deal Structure | Asset Purchase | |
| Acquirer | Bruker Corporation | |
| Public | Yes | |
| Industry | Industrials (machinery, manufacturing, construction, auto) | |
| Private equity sponsorship | No | |
| Seller | NanoString Technologies, Inc. | |
| Public | Yes | |
| Industry | Healthcare | |
| Private equity sponsorship | No | |
| Key Transaction Characteristics and Terms | ||
|---|---|---|
| Status | Pending | |
| Announcement date | April 22, 2024 | |
| Transaction value | $393 million | |
| Form of consideration | Cash | |
| Go-Shop/No-Shop Terms | ||
|---|---|---|
| No-Shop Provision | Yes | |
| Transaction Advisors | ||
|---|---|---|
| Seller / Target Counsel | ||
| Law firm #1 | Willkie Farr & Gallagher LLP | |
| Individual attorney(s) |
Rachel Strickland; Thomas Mark; Debra McElligott Sinclair; Tyler Born |
|
| Acquirer Counsel | ||
| Law firm #1 | Morgan, Lewis & Bockius LLP | |
| Individual attorney(s) |
Robert Dickey; Jennifer Feldsher |
|
| Seller / Target Financial Advisors | ||
| Financial advisor #1 | Perella Weinberg Partners LP. | |
| Acquirer Financial Advisors | ||
| Financial advisor #1 | Goldman, Sachs & Co. | |
| Financial advisor #2 | Morgan, Lewis & Bockius LLP | |